{"id":"W2593211227","doi":"10.1016/j.jaad.2016.12.014","title":"Clinical similarity of biosimilar ABP 501 to adalimumab in the treatment of patients with moderate to severe plaque psoriasis: A randomized, double-blind, multicenter, phase III study","year":2017,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":137,"is_retracted":false,"has_abstract":true,"ca_institutions":"SKiN Health; Probity Medical Research","funders":"","keywords":"Adalimumab; Medicine; Psoriasis Area and Severity Index; Clinical endpoint; Confidence interval; Psoriasis; Internal medicine; Adverse effect; Randomized controlled trial; Biosimilar; Surgery; Dermatology; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004475506,0.001091512,0.002298249,0.0004939359,0.0004918991,0.001119504,0.0009196567,0.001584254,0.004106825],"category_scores_gemma":[0.003168695,0.0007054039,0.001717399,0.0004319077,0.001317903,0.0009431541,0.0004039193,0.002461159,0.0008443253],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006859541,"about_ca_system_score_gemma":0.0013446,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003883481,"about_ca_topic_score_gemma":0.0006477642,"domain_scores_codex":[0.9982197,0.001161183,0.0001238898,0.0001971992,0.0001824417,0.0001156896],"domain_scores_gemma":[0.9973925,0.0008315746,0.0006688762,0.0002478071,0.0002002933,0.0006587468],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9418737,0.03048978,0.001526714,0.0004506525,0.0008014962,0.00005463605,0.00008659007,0.0002693906,0.00740101,0.00008080725,0.0004855466,0.01647961],"study_design_scores_gemma":[0.8225846,0.1727978,0.002849971,0.00001853792,0.0003042839,0.00005275572,0.00001847492,0.0003645637,0.0005967679,0.00006647759,0.0003324512,0.00001325867],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9935182,0.001469757,0.0006223039,0.0003059927,0.0002317476,0.002654763,0.0002383087,0.0000516846,0.0009071704],"genre_scores_gemma":[0.9938882,0.000921042,0.00124628,0.0006313444,0.0004031812,0.00185285,0.0003834783,0.00001403302,0.0006596498],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004475506,"threshold_uncertainty_score":0.023669,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05762649998465511,"score_gpt":0.4055974419265284,"score_spread":0.3479709419418732,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}